NexGen HM Protease Inhibitor Tubes—the world’s first thermally stable blood collection system designed to revolutionize biomarker preservation. Engineered with our proprietary NexGen HM Protease Inhibitor, these innovative tubes instantly inhibit endogenous protease activity at the moment of collection, safeguarding the structural and functional integrity of serum and plasma biomarkers. This cutting-edge technology eliminates the need for cold-chain logistics, reducing operational costs and logistical complexities, especially in resource-limited and tropical settings. By ensuring stable, intact biomarkers from collection to analysis, NexGen HM Protease Inhibitor Tubes enable more accurate, reliable, and cost-effective diagnostics worldwide, advancing the future of protein-based healthcare.